India, July 16 -- Shares of Abbott Laboratories were gaining around 11 percent in the early morning trading on the NYE, after the medical devices and health care company on Thursday said it has raised fiscal 2026 adjusted earnings outlook, despite reporting sharply lower profit in its second quarter. The firm recorded higher net sales in the quarter and maintained fiscal 2026 comparable sales view.
Robert Ford, chairman and chief executive officer, Abbott, said, "Our second-quarter results reflect the momentum we are building. We expect this momentum to continue and drive accelerating sales and earnings growth in the second half of the year."
Looking ahead for the third quarter, Abbott projects adjusted earnings per share of $1.38 to $1.4...